Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perceptions on Home-Administration of Biologics in the Context of Severe Asthma: An International Qualitative Study.
Flokstra-de Blok B, Kocks J, Wouters H, Arling C, Chatelier J, Douglass J, Heaney LG, Holmes J, Humbert M, Kolanowski M, Landsman JJA, Lugogo N, Malpass A, Meijer J, Metz B, de Mul B, Postma F, Leving M. Flokstra-de Blok B, et al. Among authors: humbert m. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2312-2323.e2. doi: 10.1016/j.jaip.2022.04.015. Epub 2022 Apr 27. J Allergy Clin Immunol Pract. 2022. PMID: 35487370 Free article.
Omalizumab in asthma: an update on recent developments.
Humbert M, Busse W, Hanania NA, Lowe PJ, Canvin J, Erpenbeck VJ, Holgate S. Humbert M, et al. J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):525-36.e1. doi: 10.1016/j.jaip.2014.03.010. Epub 2014 Jun 11. J Allergy Clin Immunol Pract. 2014. PMID: 25213045 Review.
Severe eosinophilic asthma: a roadmap to consensus.
Buhl R, Humbert M, Bjermer L, Chanez P, Heaney LG, Pavord I, Quirce S, Virchow JC, Holgate S; expert group of the European Consensus Meeting for Severe Eosinophilic Asthma. Buhl R, et al. Among authors: humbert m. Eur Respir J. 2017 May 1;49(5):1700634. doi: 10.1183/13993003.00634-2017. Print 2017 May. Eur Respir J. 2017. PMID: 28461308 Free article. No abstract available.
After asthma: redefining airways diseases.
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A. Pavord ID, et al. Among authors: humbert m. Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11. Lancet. 2018. PMID: 28911920 Free article. Review. No abstract available.
Controversies and opportunities in severe asthma.
Humbert M, Busse W, Hanania NA. Humbert M, et al. Curr Opin Pulm Med. 2018 Jan;24(1):83-93. doi: 10.1097/MCP.0000000000000438. Curr Opin Pulm Med. 2018. PMID: 29059087 Review.
Severe T2-high asthma in the biologics era: European experts' opinion.
Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L. Pavord I, et al. Among authors: humbert m. Eur Respir Rev. 2019 Jul 8;28(152):190054. doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30. Eur Respir Rev. 2019. PMID: 31285291 Free PMC article. Review.
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma.
Nair P, Bardin P, Humbert M, Murphy KR, Hickey L, Garin M, Vanlandingham R, Chanez P. Nair P, et al. Among authors: humbert m. J Allergy Clin Immunol Pract. 2020 Feb;8(2):555-564. doi: 10.1016/j.jaip.2019.09.036. Epub 2019 Oct 15. J Allergy Clin Immunol Pract. 2020. PMID: 31626990 Free article. Clinical Trial.
1,368 results